Company / Shareholders' Equity
TENAX THERAPEUTICS, INC. Shareholders' Equity History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$92.0M
FY2025
5-year range
-$1.8M / $92.0M
FY2021-FY2025
Trend
+1036.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +1036% YoY in FY2025, a notable deviation from the 6-year average annual change of +687%.
Based on SEC 10-K filings.
$92M in FY2025.
Improved from $60M to $92M over the past 9 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shareholders' equity increased 1036.0% year-over-year.
- Lowest shareholders' equity in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $92.0M | +1036.0% |
| FY2024 | $8.1M | -86.6% |
| FY2016 | $60.4M | +3498.3% |
| FY2015 | -$1.8M | +0.0% |
| FY2014 | -$1.8M | -413.8% |
| FY2013 | -$346.0K | +90.7% |
| FY2012 | -$3.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026